These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31795276)

  • 1. Omics-based Investigation of Diet-induced Obesity Synergized with HBx, Src, and p53 Mutation Accelerating Hepatocarcinogenesis in Zebrafish Model.
    Yang WY; Rao PS; Luo YC; Lin HK; Huang SH; Yang JM; Yuh CH
    Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31795276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight fucoidan inhibits hepatocarcinogenesis and nonalcoholic fatty liver disease in zebrafish via ASGR/STAT3/HNF4A signaling.
    Wu SY; Yang WY; Cheng CC; Lin KH; Sampurna BP; Chan SM; Yuh CH
    Clin Transl Med; 2020 Dec; 10(8):e252. PubMed ID: 33377648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish.
    Lu JW; Yang WY; Lin YM; Jin SL; Yuh CH
    Acta Histochem; 2013 Sep; 115(7):728-39. PubMed ID: 23499292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
    Zoller H; Tilg H
    Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model.
    Van Campenhout S; Tilleman L; Lefere S; Vandierendonck A; Raevens S; Verhelst X; Geerts A; Van Nieuwerburgh F; Van Vlierberghe H; Devisscher L
    Metabolism; 2020 Jun; 107():154220. PubMed ID: 32243868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating Pathogenic and Hepatocarcinogenic Mechanisms from Normal Liver to HCC by Constructing Genetic and Epigenetic Networks via Big Genetic and Epigenetic Data Mining and Genome-Wide NGS Data Identification.
    Li CW; Chiu YK; Chen BS
    Dis Markers; 2018; 2018():8635329. PubMed ID: 30344796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
    Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
    Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in mouse models of obesity- and nonalcoholic steatohepatitis-associated hepatocarcinogenesis.
    Nakagawa H
    World J Hepatol; 2015 Aug; 7(17):2110-8. PubMed ID: 26301053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome analysis on the inflammatory cell infiltration of nonalcoholic steatohepatitis in bama minipigs induced by a long-term high-fat, high-sucrose diet.
    Xia J; Yuan J; Xin L; Zhang Y; Kong S; Chen Y; Yang S; Li K
    PLoS One; 2014; 9(11):e113724. PubMed ID: 25415189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
    Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
    Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocarcinogenesis in viral Hepatitis B infection: the role of HBx and p53.
    Dewantoro O; Gani RA; Akbar N
    Acta Med Indones; 2006; 38(3):154-9. PubMed ID: 16953033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Molecular Weight Fucoidan Prevents Radiation-Induced Fibrosis and Secondary Tumors in a Zebrafish Model.
    Wu SY; Yang WY; Cheng CC; Hsiao MC; Tsai SL; Lin HK; Lin KH; Yuh CH
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32570707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of hepatocarcinogenesis.
    Sheu JC
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S309-13. PubMed ID: 9407351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.
    Tucker RD; Ciofoaia V; Nadella S; Gay MD; Cao H; Huber M; Safronenka A; Shivapurkar N; Kallakury B; Kruger AJ; Kroemer AHK; Smith JP
    Dig Dis Sci; 2020 Jan; 65(1):189-203. PubMed ID: 31297627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of p53 and p21 during hepatocarcinogenesis in tree shrews.
    Su JJ; Ban KC; Li Y; Qin LL; Wang HY; Yang C; Ou C; Duan XX; Lee YL; Yang RQ
    World J Gastroenterol; 2004 Dec; 10(24):3559-63. PubMed ID: 15534906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBx-K130M/V131I Promotes Liver Cancer in Transgenic Mice via AKT/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism.
    Chiu AP; Tschida BR; Sham TT; Lo LH; Moriarity BS; Li XX; Lo RC; Hinton DE; Rowlands DK; Chan CO; Mok DKW; Largaespada DA; Warner N; Keng VW
    Mol Cancer Res; 2019 Jul; 17(7):1582-1593. PubMed ID: 30975706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma.
    Huang JL; Ren TY; Cao SW; Zheng SH; Hu XM; Hu YW; Lin L; Chen J; Zheng L; Wang Q
    Oncotarget; 2015 Oct; 6(32):33791-804. PubMed ID: 26393879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis.
    Marengo A; Rosso C; Bugianesi E
    Annu Rev Med; 2016; 67():103-17. PubMed ID: 26473416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.